Abstract
In this study we have demonstrated that the human promyelocytic leukaemia cell line (HL-60 cells) completely lack the biological functions of chemotaxis and degranulation. In addition, they were also unable to bind the anti-neutrophil monoclonal antibody NCD 1 which has been shown to inhibit these functions in the peripheral blood neutrophil. When HL-60 cells were induced to differentiate by culturing for 6 days at 37 degrees C in the presence of either 1.25% dimethylsulphoxide (DMSO) or 0.5% dimethylformamide (DMF), up to 35% bound NCD 1. Differentiated HL-60 cells are capable of chemotaxis, degranulation and these newly acquired functions were inhibited by NCD 1 in a manner similar to that seen for the peripheral blood neutrophil. The results correlate the appearance of an antigen on the cell surface of DMSO- or DMF-induced HL-60 cells with the acquisition of two specific cellular functions.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bentwood B. J., Henson P. M. The sequential release of granule constitutents from human neutrophils. J Immunol. 1980 Feb;124(2):855–862. [PubMed] [Google Scholar]
- Collins S. J., Gallo R. C., Gallagher R. E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 1977 Nov 24;270(5635):347–349. doi: 10.1038/270347a0. [DOI] [PubMed] [Google Scholar]
- Collins S. J., Ruscetti F. W., Gallagher R. E., Gallo R. C. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med. 1979 Apr 1;149(4):969–974. doi: 10.1084/jem.149.4.969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Collins S. J., Ruscetti F. W., Gallagher R. E., Gallo R. C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci U S A. 1978 May;75(5):2458–2462. doi: 10.1073/pnas.75.5.2458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cotter T. G., Spears P., Henson P. M. A monoclonal antibody inhibiting human neutrophil chemotaxis and degranulation. J Immunol. 1981 Oct;127(4):1355–1360. [PubMed] [Google Scholar]
- Henson P. M., Zanolari B., Schwartzman N. A., Hong S. R. Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B. J Immunol. 1978 Sep;121(3):851–855. [PubMed] [Google Scholar]
- Niedel J., Kahane I., Lachman L., Cuatrecasas P. A subpopulation of cultured human promyelocytic leukemia cells (HL-60) displays the formyl peptide chemotactic receptor. Proc Natl Acad Sci U S A. 1980 Feb;77(2):1000–1004. doi: 10.1073/pnas.77.2.1000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Segal A. W. The antimicrobial role of the neutrophil leukocyte. J Infect. 1981 Mar;3(1):3–17. doi: 10.1016/s0163-4453(81)92161-7. [DOI] [PubMed] [Google Scholar]
- Webster R. O., Hong S. R., Johnston R. B., Jr, Henson P. M. Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function. Immunopharmacology. 1980 Jun;2(3):201–219. doi: 10.1016/0162-3109(80)90050-8. [DOI] [PubMed] [Google Scholar]
- Zigmond S. H., Hirsch J. G. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973 Feb 1;137(2):387–410. doi: 10.1084/jem.137.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
